TrialBMC cancer2016
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
Elizabeth J Davis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.